Skip to content Skip to navigation


The Strategic Advisory Board (SAB) is composed of world-leading experts in stem cell and biomaterials technologies. CCRM shares its SAB with the Ontario Institute for Regenerative Medicine (OIRM).

Co- Chairs

  • Janet Rossant, Hospital for Sick Children Research Institute, Canada
  • Peter Zandstra, Centre for Commercialization of Regenerative Medicine, Canada


  • Jeffrey Hubbell, The University of Chicago, USA
  • Douglas Lauffenburger, Massachusetts Institute of Technology, USA
  • Chris Mason, AVROBIO, USA
  • Kathrin Plath, University of California, USA
  • Michael Sefton, University of Toronto, Canada
  • Toshio Suda, National University of Singapore, Singapore
  • Jakub Tolar, University of Minnesota, USA
  • Fiona Watt, King's College London, UK

Honourary Member

  • Shinya Yamanaka, Centre for iPS Cell Research and Application, Japan

The role of the Founders Advisory Board (FAB) is to provide guidance, contacts and environment scanning for CCRM's activities, and act in an advisory capacity for CCRM's operations.

  • Mick Bhatia, McMaster Stem Cell and Cancer Research Institute, Hamilton
  • James Ellis, SickKids Research Institute, Toronto
  • Armand Keating, University Health Network, Toronto
  • Gordon Keller, McEwen Stem Cell Institute and University Health Network, Toronto
  • Andras Nagy, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto
  • Janet Rossant, SickKids Research Institute, Toronto
  • Michael Rudnicki, Ottawa Hospital Research Institute, Ottawa
  • Paul Santerre, Institute of Biomaterials & Biomedical Engineering, University of Toronto, Toronto
  • Molly Shoichet, Institute of Biomaterials & Biomedical Engineering, University of Toronto, Toronto
  • Bill Stanford, Ottawa Hospital Research Institute, Ottawa
  • Peter Zandstra, CCRM, Toronto